With the goal of making clinical trials more and more patient-centric, decentralization has introduced newer complexities in clinical development.
A large part of clinical trial data today comes in through non-EDC or external sources, which makes data handling more complex. RBDM is an end-to end risk-based approach with an aim to enable ongoing risk and data surveillance for better control and expedited database locks.
To know more about how we help our clients implement RBDM, download this brochure or drop us a line at hello@algorics.com